Molecular Devices, One Cell Systems, First Annual Cell Signaling Symposium, CellFactors and Cytomyx Holdings, Neurogen, Palo Alto Research Center and Scripps Research Institute, and Beckman Coulter | GenomeWeb

Molecular Devices Posts Best Quarter in its History

Molecular Devices of Sunnyvale, Calif., announced on April 22 that its 2004 first-quarter earnings and revenues set a record for the company.

Revenues for the quarter, which ended March 31, were $27.3 million, an increase of 11 percent compared to the first quarter of last year, the company said. In addition, operating income for the first quarter of 2004 was $2.2 million, an increase of 198 percent compared to the first quarter of 2003.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.